← Open Payments lookup

LAUREN MCMANAMAY: Open Payments

NPI 1932884491 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,503 in 113 payments from 17 companies in 2025. Trend: 2023 $612 · 2024 $2,403 · 2025 $2,503

Food & beverage: $2,503
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$454
Alkermes, Inc.10$221
Vanda Pharmaceuticals Inc.8$211
ABBVIE INC.16$200
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$194
E.R. Squibb & Sons, L.L.C.11$186
Axsome Therapeutics, Inc.7$182
Biogen, Inc.3$177
Janssen Pharmaceuticals, Inc6$166
Collegium Pharmaceutical, Inc.6$107

Products named: INGREZZA, VRAYLAR, CAPLYTA, ARISTADA, FANAPT, COBENFY, Auvelity, ZURZUVAE.

Industry payments across VA — which companies pay providers there.